Barclays Bank Ireland PLC

Pillar 3 Terms and Conditions of own funds and eligible liabilities

30 June 2020

Supplement to the Barclays Bank Ireland PLC Pillar 3 Report 2019

Introductory notes

This worksheet complements the Barclays Bank Ireland PLC Pillar 3 Interim Report 2020, available from home.barclays/investor-relations/reports-and-events/annual-reports/

The information disclosed in this report is prepared in accordance with the Capital Requirements Regulation and Capital Requirements Directive (CRR and CRD, also known as the 'CRD IV legislative package'). On 27 June 2019, CRR II came into force amending CRR. As an amending regulation, the existing provisions of CRR apply unless they are amended by CRR II.

The Pillar 3 disclosures have also been prepared in accordance with the EBA "Guidelines on materiality, proprietary and confidentiality and on disclosure frequency under Articles 432(1), 432(2) and 433 of CRR" and European Banking Authority (EBA) "Guidelines on disclosure requirements under Part Eight of Regulation (EU) No 575/2013", as amended by Regulation (EU) 2019/876, in effect at the reporting date, using the uniform format set out in the BCBS standard on Pillar 3 disclosure requirements, as the EU format for disclosure is yet to be agreed. Certain aspects of CRR II are dependent on final technical standards to be issued by the EBA and adopted by the European Commission.

The disclosures reflect Barclays Bank Ireland PLC's interpretation of the current rules and guidance. The abbreviations '€m' and '€bn' represent millions and thousands of millions of Euros respectively.

Forward looking statements

Readers are cautioned that no forward-looking statement is a guarantee of future performance and that actual results or other financial condition or performance measures could differ materially from those contained in the forward- looking statements. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements sometimes use words such as 'may', 'will', 'seek', 'continue', 'aim', 'anticipate', 'target', 'projected', 'expect', 'estimate', 'intend', 'plan', 'goal', 'believe', 'achieve' or other words of similar meaning.

Forward-looking statements can be made in writing but also may be made verbally by members of the management of Barclays Bank Ireland PLC (the 'Bank') (including, without limitation, during management presentations to financial analysts) in connection with this document. Examples of forward-looking statements include, among others, statements or guidance regarding or relating to the Bank's future financial position, income growth, assets, impairment charges, provisions, business strategy, capital, leverage and other regulatory ratios, payment of dividends (including dividend payout ratios and expected payment strategies), projected levels of growth in the banking and financial markets, projected costs or savings, any commitments and targets, estimates of capital expenditures, plans and objectives for future operations, projected employee numbers, IFRS impacts and other statements that are not historical fact. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances. The forward-looking statements speak only as at the date on which they are made and such statements may be affected by changes in legislation, the development of standards and interpretations under IFRS, including evolving practices with regard to the interpretation and application of accounting and regulatory standards, the outcome of current and future legal proceedings and regulatory investigations, future levels of conduct provisions, the policies and actions of governmental and regulatory authorities, geopolitical risks and the impact of competition. In addition, factors including (but not limited to) the following may have an effect: capital, leverage and other regulatory rules applicable to past, current and future periods; Eurozone and global macroeconomic and business conditions; the effects of any volatility in credit markets; market related risks such as changes in interest rates and foreign exchange rates; effects of changes in valuation of credit market exposures; changes in valuation of issued securities; volatility in capital markets; changes in credit ratings of the Bank or any securities issued by the Bank; direct and indirect impacts of the coronavirus (COVID-19) pandemic; instability as a result of the exit by the UK from the European Union and the disruption that may subsequently result in Ireland, the EU and globally; and the success of future acquisitions, disposals and other strategic transactions. A number of these influences and factors are beyond the Bank's control. As a result, the Bank actual financial position, future results, dividend payments, capital, leverage or other regulatory ratios or other financial and non-financial metrics or performance measures may differ materially from the statements or guidance set forth in the Bank's forward-looking statements. Additional risks and factors which may impact the Bank's future financial condition and performance are identified in the Bank's 2019 Annual Report and the Bank's 2020 Interim Report which are available on Barclays' website at https://home.barclays/investor-relations/.

Subject to our obligations under the applicable laws and regulations of any relevant jurisdiction, (including, without limitation, Ireland), in relation to disclosure and ongoing information, we undertake no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Capital instruments main features template

1

Issuer

Barclays Bank Ireland PLC

Barclays Bank Ireland PLC

Barclays Bank Ireland PLC

Barclays Bank Ireland PLC

2

Unique identifier (eg CUSIP, ISIN or Bloomberg identifier for private placement)

N/A

N/A

N/A

3

Governing law(s) of the instrument

Irish

Irish

Irish

Irish

3a

Means by which enforceability requirement of Section 13 of the TLAC Term Sheet is

N/A

N/A

N/A

N/A

achieved (for other TLAC-eligible instruments governed by foreign law)

4

Transitional Basel III rules

Common Equity Tier 1

Additional Tier 1

Additional Tier 1

Additional Tier 1

5

Post-transitional Basel III rules

Common Equity Tier 1

Additional Tier 1

Additional Tier 1

Additional Tier 1

6

Eligible at solo/group/group and solo

Solo

Solo

Solo

Solo

7

Instrument type (types to be specified by each jurisdiction)

Ordinary Share Capital

Perpetual Deeply Subordinated Write

Perpetual Deeply Subordinated Write

Perpetual Deeply Subordinated Write

Down Securities

Down Securities

Down Securities

8

Amount recognised in regulatory capital (Currency in million, as of most recent

€810m

€300m

€69m

€36m

reporting date)

9

Par value of instrument

€1.00

€300m

€69m

€36m

10

Accounting classification

Shareholders' equity

Shareholders' equity

Shareholders' equity

Shareholders' equity

11

Original date of issuance

12/01/2005

30/11/2018

23/03/2019

26/04/2019

12

Perpetual or dated

Perpetual

Perpetual

Perpetual

Perpetual

13

Original maturity date

No maturity

No maturity

No maturity

No maturity

14

Issuer call subject to prior supervisory approval

N/A

Yes

Yes

Yes

15

Optional call date, contingent call dates and redemption amount

N/A

Optional call on 15/12/2023 at 100%.

Optional call on 22/03/2024 at 100%.

Optional call on 26/04/2024 at 100%.

Also tax and regulatory event calls

Also tax and regulatory event calls

Also tax and regulatory event calls

16

Subsequent call dates, if applicable

N/A

Any Interest Payment Date

Any Interest Payment Date

Any Interest Payment Date

Coupons / dividends

17

Fixed or floating dividend/coupon

N/A

Floating

Floating

Floating

18

Coupon rate and any related index

N/A

1 month EURIBOR plus 7.356%

1 month EURIBOR plus 6.682%

1 month EURIBOR plus 5.95%

19

Existence of a dividend stopper

No

No

No

No

20a

Fully discretionary, partially discretionary or mandatory (in terms of timing)

Fully discretionary

Fully discretionary

Fully discretionary

Fully discretionary

20b

Fully discretionary, partially discretionary or mandatory (in terms of amount)

Fully discretionary

Fully discretionary

Fully discretionary

Fully discretionary

21

Existence of step-up or other incentive to redeem

No

No

No

No

22

Non-cumulative or cumulative

Non-cumulative

Non-cumulative

Non-cumulative

Non-cumulative

23

Convertible or non-convertible

Non-convertible

Non-convertible

Non-convertible

Non-convertible

24

If convertible, conversion trigger(s)

N/A

N/A

N/A

N/A

25

If convertible, fully or partially

N/A

N/A

N/A

N/A

26

If convertible, conversion rate

N/A

N/A

N/A

N/A

27

If convertible, mandatory or optional conversion

N/A

N/A

N/A

N/A

28

If convertible, specify instrument type convertible into

N/A

N/A

N/A

N/A

29

If convertible, specify issuer of instrument it converts into

N/A

N/A

N/A

N/A

30

Write-down features

No

Yes

Yes

Yes

31

If write-down,write-down trigger(s)

N/A

Barclays Bank Ireland PLC Transitional

Barclays Bank Ireland PLC Transitional

Barclays Bank Ireland PLC Transitional

Common Equity Tier 1 ratio falls below 7%

Common Equity Tier 1 ratio falls below 7%

Common Equity Tier 1 ratio falls below 7%

32

If write-down, full or partial

N/A

Partial

Partial

Partial

33

If write-down, permanent or temporary

N/A

Permanent

Permanent

Permanent

34

If temporary write-down, description of write-up mechanism

N/A

N/A

N/A

N/A

34a

Type of subordination

Statutory

Contractual

Contractual

Contractual

35

Position in subordination hierarchy in liquidation (specify instrument type

Perpetual Deeply Subordinated Write

Dated Subordinated Debt

Dated Subordinated Debt

Dated Subordinated Debt

immediately senior to instrument in the insolvency creditor hierarchy of the legal

Down Securities

entity concerned)

36

Non-compliant transitioned features

No

No

No

No

37

If yes, specify non-compliant features

N/A

N/A

N/A

N/A

Capital instruments main features template

1

Issuer

Barclays Bank Ireland PLC

Barclays Bank Ireland PLC

Barclays Bank Ireland PLC

Barclays Bank Ireland PLC

2

Unique identifier (eg CUSIP, ISIN or Bloomberg identifier for private placement)

N/A

N/A

N/A

N/A

3

Governing law(s) of the instrument

Irish

Irish

English

English

3a

Means by which enforceability requirement of Section 13 of the TLAC Term Sheet is

N/A

N/A

N/A

N/A

achieved (for other TLAC-eligible instruments governed by foreign law)

4

Transitional Basel III rules

Additional Tier 1

Additional Tier 1

Tier 2

Tier 2

5

Post-transitional Basel III rules

Additional Tier 1

Additional Tier 1

Tier 2

Tier 2

6

Eligible at solo/group/group and solo

Solo

Solo

Solo

Solo

7

Instrument type (types to be specified by each jurisdiction)

Perpetual Deeply Subordinated Write

Perpetual Deeply Subordinated Write

Dated Subordinated Debt

Dated Subordinated Debt

Down Securities

Down Securities

8

Amount recognised in regulatory capital (Currency in million, as of most recent

€85m

€75m

€375m

€56m

reporting date)

9

Par value of instrument

€85m

€75m

€375m

€56m

10

Accounting classification

Shareholders' equity

Shareholders' equity

Liability - amortised cost

Liability - amortised cost

11

Original date of issuance

04/07/2019

27/09/2019

01/03/2019

08/03/2019

12

Perpetual or dated

Perpetual

Perpetual

Dated

Dated

13

Original maturity date

No maturity

No maturity

01/03/2029

08/03/2029

14

Issuer call subject to prior supervisory approval

Yes

Yes

Yes

Yes

15

Optional call date, contingent call dates and redemption amount

Optional call on 15/07/2024 at 100%.

Optional call on 27/09/2024 at 100%.

01/03/2024 at 100% plus tax and

08/03/2024 at 100% plus tax and

Also tax and regulatory event calls

Also tax and regulatory event calls

regulatory event calls

regulatory event calls

16

Subsequent call dates, if applicable

Any Interest Payment Date

Any Interest Payment Date

Any Interest Payment Date

Any Interest Payment Date

Coupons / dividends

17

Fixed or floating dividend/coupon

Floating

Floating

Floating

Floating

18

Coupon rate and any related index

1 month EURIBOR plus 6.24%

1 month EURIBOR plus 6.24%

1 month EURIBOR plus 4.04%

1 month EURIBOR plus 3.851%

19

Existence of a dividend stopper

No

No

No

No

20a

Fully discretionary, partially discretionary or mandatory (in terms of timing)

Fully discretionary

Fully discretionary

Mandatory

Mandatory

20b

Fully discretionary, partially discretionary or mandatory (in terms of amount)

Fully discretionary

Fully discretionary

Mandatory

Mandatory

21

Existence of step-up or other incentive to redeem

No

No

No

No

22

Non-cumulative or cumulative

Non-cumulative

Non-cumulative

Cumulative

Cumulative

23

Convertible or non-convertible

Non-convertible

Non-convertible

Non-convertible

Non-convertible

24

If convertible, conversion trigger(s)

N/A

N/A

N/A

N/A

25

If convertible, fully or partially

N/A

N/A

N/A

N/A

26

If convertible, conversion rate

N/A

N/A

N/A

N/A

27

If convertible, mandatory or optional conversion

N/A

N/A

N/A

N/A

28

If convertible, specify instrument type convertible into

N/A

N/A

N/A

N/A

29

If convertible, specify issuer of instrument it converts into

N/A

N/A

N/A

N/A

30

Write-down features

Yes

Yes

No

No

31

If write-down,write-down trigger(s)

Barclays Bank Ireland PLC Transitional

Barclays Bank Ireland PLC Transitional

N/A

N/A

Common Equity Tier 1 ratio falls below 7%

Common Equity Tier 1 ratio falls below 7%

32

If write-down, full or partial

Partial

Partial

N/A

N/A

33

If write-down, permanent or temporary

Permanent

Permanent

N/A

N/A

34

If temporary write-down, description of write-up mechanism

N/A

N/A

N/A

N/A

34a

Type of subordination

Contractual

Contractual

Contractual

Contractual

35

Position in subordination hierarchy in liquidation (specify instrument type

Dated Subordinated Debt

Dated Subordinated Debt

Dated secondary non-preferential debt

Dated secondary non-preferential debt

immediately senior to instrument in the insolvency creditor hierarchy of the legal

entity concerned)

36

Non-compliant transitioned features

No

No

No

No

37

If yes, specify non-compliant features

N/A

N/A

N/A

N/A

Capital instruments main features template

1

Issuer

Barclays Bank Ireland PLC

Barclays Bank Ireland PLC

Barclays Bank Ireland PLC

Barclays Bank Ireland PLC

2

Unique identifier (eg CUSIP, ISIN or Bloomberg identifier for private placement)

N/A

N/A

N/A

N/A

3

Governing law(s) of the instrument

Irish

Irish

Irish

Irish

3a

Means by which enforceability requirement of Section 13 of the TLAC Term Sheet is

N/A

N/A

N/A

N/A

achieved (for other TLAC-eligible instruments governed by foreign law)

4

Transitional Basel III rules

Tier 2

Tier 2

Eligible Liabilities

Eligible Liabilities

5

Post-transitional Basel III rules

Tier 2

Tier 2

Eligible Liabilities

Eligible Liabilities

6

Eligible at solo/group/group and solo

Solo

Solo

Solo

Solo

7

Instrument type (types to be specified by each jurisdiction)

Dated Subordinated Debt

Dated Subordinated Debt

Non-preferred senior unsecured debt

Non-preferred senior unsecured debt

8

Amount recognised in regulatory capital (Currency in million, as of most recent

€95m

€39m

€200m

€125m

reporting date)

9

Par value of instrument

€95m

€39m

€200m

€125m

10

Accounting classification

Liability - amortised cost

Liability - amortised cost

Liability - amortised cost

Liability - amortised cost

11

Original date of issuance

22/03/2019

26/04/2019

13/12/2018

01/03/2019

12

Perpetual or dated

Dated

Dated

Dated

Dated

13

Original maturity date

22/03/2029

26/04/2031

13/12/2022

01/03/2024

14

Issuer call subject to prior supervisory approval

Yes

Yes

Yes

Yes

15

Optional call date, contingent call dates and redemption amount

22/03/2024 at 100% plus tax and

26/04/2026 at 100% plus tax and

100%

100%

regulatory event calls

regulatory event calls

16

Subsequent call dates, if applicable

Any Interest Payment Date

Any Interest Payment Date

N/A

N/A

Coupons / dividends

17

Fixed or floating dividend/coupon

Floating

Floating

Floating

Floating

18

Coupon rate and any related index

1 month EURIBOR plus 3.855%

1 month EURIBOR plus 3.32%

1 month EURIBOR plus 2.293%

1 month EURIBOR plus 1.79%

19

Existence of a dividend stopper

No

No

No

No

20a

Fully discretionary, partially discretionary or mandatory (in terms of timing)

Mandatory

Mandatory

Mandatory

Mandatory

20b

Fully discretionary, partially discretionary or mandatory (in terms of amount)

Mandatory

Mandatory

Mandatory

Mandatory

21

Existence of step-up or other incentive to redeem

No

No

No

No

22

Non-cumulative or cumulative

Cumulative

Cumulative

Cumulative

Cumulative

23

Convertible or non-convertible

Non-convertible

Non-convertible

Non-convertible

Non-convertible

24

If convertible, conversion trigger(s)

N/A

N/A

N/A

N/A

25

If convertible, fully or partially

N/A

N/A

N/A

N/A

26

If convertible, conversion rate

N/A

N/A

N/A

N/A

27

If convertible, mandatory or optional conversion

N/A

N/A

N/A

N/A

28

If convertible, specify instrument type convertible into

N/A

N/A

N/A

N/A

29

If convertible, specify issuer of instrument it converts into

N/A

N/A

N/A

N/A

30

Write-down features

No

No

No

No

31

If write-down,write-down trigger(s)

N/A

N/A

N/A

N/A

32

If write-down, full or partial

N/A

N/A

N/A

N/A

33

If write-down, permanent or temporary

N/A

N/A

N/A

N/A

34

If temporary write-down, description of write-up mechanism

N/A

N/A

N/A

N/A

34a

Type of subordination

Contractual

Contractual

Contractual

Contractual

35

Position in subordination hierarchy in liquidation (specify instrument type

Dated secondary non-preferential debt

Dated secondary non-preferential debt

Senior unsecured liabilities

Senior unsecured liabilities

immediately senior to instrument in the insolvency creditor hierarchy of the legal

entity concerned)

36

Non-compliant transitioned features

No

No

No

No

37

If yes, specify non-compliant features

N/A

N/A

N/A

N/A

Attachments

  • Original document
  • Permalink

Disclaimer

Barclays plc published this content on 09 October 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 October 2020 12:24:01 UTC